AI Governance in Healthcare Simple Policies for Transparency Privacy and Ethics
- MLJ CONSULTANCY LLC
- 2 hours ago
- 17 min read
A hospital can use artificial intelligence to flag a possible stroke on an image, predict which patients may miss follow-up visits, or help staff summarize long clinical notes. Those tools can save time and support care, but they can also make mistakes, use sensitive data in the wrong way, or treat groups of patients unfairly.
That is why healthcare organizations need clear rules before artificial intelligence becomes part of daily work.
AI governance in simple terms means the policies, roles, and checks that guide how artificial intelligence is chosen, tested, used, monitored, and retired. It answers basic questions:
Who approved this tool?
What data does it use?
How accurate is it for different patient groups?
Who is responsible if it gives a poor recommendation?
How will patients know artificial intelligence is involved?
How will the organization protect private health information?
This post explains the essential policies every healthcare organization should put in place. It uses plain language, practical examples, and widely accepted guidance from sources such as the Health Insurance Portability and Accountability Act, the U.S. Food and Drug Administration, the National Institute of Standards and Technology, and the World Health Organization.
This article is for general information only. It is not legal, medical, or compliance advice.
Why artificial intelligence needs governance in healthcare
Artificial intelligence is not one thing. It can be a simple rule-based tool, a prediction system, a chatbot, an image-reading aid, or a system that helps sort clinical messages. Some tools affect care directly. Others affect billing, scheduling, staffing, or patient outreach.
Healthcare raises the stakes because artificial intelligence may affect:
Patient safety
Diagnosis and treatment decisions
Access to care
Insurance and billing
Privacy of medical records
Trust between patients and care teams
A scheduling tool that suggests appointment times may seem low risk. A tool that helps detect a tumor on a scan carries much higher risk. Both need rules, but the level of review should match the possible harm.
The National Institute of Standards and Technology describes artificial intelligence risk management as a process of mapping risks, measuring them, managing them, and monitoring them over time. In healthcare, that means organizations should not only ask whether a tool works. They should ask whether it works safely, fairly, privately, and consistently in their own setting.
A common mistake is treating artificial intelligence like ordinary software. Ordinary software usually follows fixed instructions. Artificial intelligence often finds patterns in data and may behave differently when the data changes. For example, a tool trained mostly on records from one region may perform less well in another community. A tool built with older data may miss changes in current care practices.
Governance helps close that gap. It turns artificial intelligence from a vague promise into a controlled part of care delivery.
Key concepts in plain English
Before building policies, everyone needs a shared vocabulary. These definitions avoid technical wording where possible.
Artificial intelligence
Artificial intelligence is software that performs tasks that usually require human judgment, such as recognizing patterns, ranking risks, generating language, or making predictions.
In healthcare, examples include:
A tool that flags chest imaging for urgent review
A system that predicts which patients may need extra discharge support
A program that summarizes patient messages for a clinician
A chatbot that answers general questions about clinic hours or preparation instructions
Artificial intelligence should support qualified staff. It should not replace clinical judgment where patient care decisions require a licensed professional.
Model
A model is the part of the system that produces an answer, prediction, ranking, or suggestion. It may estimate the chance of readmission, sort messages by urgency, or draft a note.
A model is only as useful as its design, training data, testing, and use in real conditions.
Training data
Training data is the information used to build or tune an artificial intelligence tool. In healthcare, this might include medical images, lab values, visit notes, appointment history, or claims records.
Poor training data can lead to poor results. If a tool was built using data that does not reflect the patients a clinic serves, it may produce less reliable suggestions.
Bias
Bias means a tool performs differently or unfairly for certain groups. Bias can involve race, age, sex, disability, language, income, geography, insurance status, or other factors.
For example, a prediction tool may underestimate risk for patients who have less frequent visits because they face transportation barriers. The tool might read fewer visits as lower need, when the real issue is poor access to care.
Transparency
Transparency means people can understand when artificial intelligence is being used, why it is being used, what it does, and what its limits are.
Transparency does not always mean everyone can see every technical detail. It means the right people get understandable information for their role. A patient may need a short explanation. A clinician may need performance details and safe-use instructions. A review committee may need testing results and privacy analysis.
Accountability
Accountability means a named person or group is responsible for decisions about artificial intelligence use. It also means the organization can explain what happened when something goes wrong.
A safe policy does not say, “The tool made the decision.” It says who reviewed the tool, who approved it, who monitors it, and who acts when concerns arise.
Data privacy
Data privacy means protecting personal health information from improper use, access, sharing, or exposure. In the United States, the Health Insurance Portability and Accountability Act sets national standards for protecting certain health information. Many states also have their own privacy and security laws.
Artificial intelligence can create privacy risks because these tools often need large amounts of data. Governance sets boundaries around what data may be used, who may use it, and how it must be protected.
The essential policies every healthcare organization should implement
A good governance program does not need to start with a long rulebook. It should start with practical policies that answer the most important questions.
The table below gives a simple overview.
Policy | Main question it answers | Practical example |
Approval and inventory policy | What tools are we using, and who approved them? | A clinic keeps a list of all artificial intelligence tools used in imaging, scheduling, billing, and patient messages. |
Risk classification policy | How much harm could this tool cause? | A tool that suggests lunch staffing levels is low risk. A tool that flags possible sepsis is high risk. |
Data use and privacy policy | What information may the tool use? | A chatbot for appointment questions may not receive full medical records unless clearly approved. |
Transparency policy | Who must be told that artificial intelligence is involved? | Clinicians see a notice when a draft note was generated by artificial intelligence. |
Human review policy | When must a person check the output? | A clinician must review any care-related recommendation before it affects treatment. |
Fairness and bias policy | Does the tool work well for different patient groups? | The organization checks performance across age groups, languages, and insurance types. |
Monitoring policy | Is the tool still safe and useful over time? | A monthly review tracks errors, complaints, and changes in accuracy. |
Vendor and third-party policy | What must outside suppliers prove? | A supplier must explain data use, security controls, testing, and limits. |
Incident response policy | What happens if something goes wrong? | Staff know how to report a harmful recommendation or privacy concern. |
Retirement policy | When should the organization stop using a tool? | A tool is removed if monitoring shows repeated unsafe results. |
These policies work best when they connect to existing patient safety, privacy, compliance, and quality programs.
Create an approval and inventory policy
The first rule is simple. No one should use artificial intelligence in healthcare work unless the organization knows about it.
An approval and inventory policy requires every tool to be reviewed and listed before use. This includes tools built in-house, tools bought from outside suppliers, and tools added quietly into existing software.
The inventory should include:
Tool name and purpose
Department using it
Type of data used
Patient care impact
Date approved
Person or group responsible
Known limits
Review schedule
Status, such as testing, active use, paused, or retired
This may sound basic, but it solves a real problem. Artificial intelligence can enter a healthcare organization through many doors. One department may test a note-writing tool. Another may use a prediction model for patient outreach. A third may receive artificial intelligence features inside software it already uses.
Without an inventory, leaders cannot manage risk because they do not know what exists.
A practical policy might say:
All artificial intelligence tools must be registered before use.
Tools that touch patient care require formal review.
Tools using patient information require privacy review.
Staff may not paste patient information into unapproved tools.
The inventory must be updated at least quarterly.
This policy supports safety, privacy, and accountability at the same time.
Classify risk before use
Not every artificial intelligence tool needs the same level of review. A tool that drafts a cafeteria menu does not create the same risk as a tool that suggests a diagnosis.
A risk classification policy helps the organization decide how much review is needed. The National Institute of Standards and Technology recommends considering the context of use, possible harms, and who may be affected. In healthcare, the most important question is whether the tool could influence patient care or patient rights.
A simple risk scale can work well.
Low risk tools
Low risk tools do not use sensitive clinical information and do not affect care decisions.
Examples include:
Sorting general website questions
Helping staff write non-clinical training materials
Forecasting supply levels without patient details
These tools still need approval, but they may not need a full clinical safety review.
Medium risk tools
Medium risk tools may affect operations, patient communication, or administrative decisions.
Examples include:
Prioritizing appointment reminders
Drafting patient education text for review
Suggesting staffing levels based on past visit volume
These tools need privacy review, human oversight, and monitoring.
High risk tools
High risk tools can influence diagnosis, treatment, triage, medication decisions, discharge planning, or access to care.
Examples include:
Flagging possible sepsis
Reviewing imaging for urgent findings
Predicting suicide risk
Recommending care management services
Ranking transplant or specialty referral priority
These tools need the strongest controls. They should be tested in the local setting, reviewed by clinical leaders, checked for bias, monitored often, and paused if safety concerns appear.
Risk can change. A tool used only for research may become high risk if staff begin using it in patient care. Governance should require a new review when use changes.
Protect patient data with clear privacy rules
Data privacy sits at the center of healthcare artificial intelligence. Patient information is sensitive, personal, and often permanent. A lab result or diagnosis cannot be changed like a password.
A strong data use and privacy policy should cover the full life of the data.
Limit data to what is needed
Artificial intelligence tools should use only the information needed for the approved purpose. This is called data minimization.
For example, a tool that sends appointment reminders may need a patient’s name, contact preference, appointment time, and clinic location. It likely does not need diagnoses, lab results, or medication lists.
Use de-identified data when possible
De-identified data means information has been processed so it no longer identifies a specific person under accepted legal or policy standards. It is often useful for testing and quality review.
De-identification does not solve every privacy issue. Sometimes data can still carry risk when combined with other information. The policy should define when de-identified data is acceptable and who verifies it.
Keep patient information out of unapproved tools
Staff should not enter patient names, visit notes, images, messages, or other health details into tools that have not been approved. This should be stated plainly in training.
A safe rule is:
If a tool has not been approved for patient information, do not put patient information into it.
Set access controls
Only people with a valid work need should have access to data used by artificial intelligence tools. Access should be reviewed regularly.
The policy should define:
Who may view input data
Who may view outputs
Who may export data
Who may approve new data connections
How access is removed when roles change
Review outside suppliers
If an outside supplier handles patient information, the healthcare organization needs written terms that address privacy, security, data use, breach reporting, and data return or deletion.
This is not only good practice. In many cases, privacy law requires formal agreements when another organization handles protected health information on behalf of a healthcare provider or health plan.
Make transparency part of everyday use
Transparency builds trust because it reduces confusion. It also helps staff catch errors.
A transparency policy should explain what information is shared with patients, clinicians, staff, and leaders.
Tell clinicians what the tool does and does not do
Clinicians need practical information, not technical clutter. They should know:
What the tool is intended to support
What data it uses
What output it gives
What the output means
What the output does not mean
When they must use their own judgment
How to report concerns
For example, if a model predicts readmission risk, clinicians should know whether the score reflects medical complexity, past admissions, social factors, or a mix of many inputs. They should also know that a high score is not a diagnosis. It is a signal to review the patient’s needs.
Tell patients when it matters
Patients do not need a lecture on software design. They do deserve plain explanations when artificial intelligence plays a meaningful role in their care or communication.
Examples of patient-facing explanations include:
“A computer tool helped prioritize this message, and a member of your care team reviewed it.”
“This draft was created with software support and checked by your clinician.”
“This tool helps identify patients who may benefit from follow-up support. Your care team makes the final decision.”
Some uses may not require direct patient notice, such as internal supply planning. Other uses clearly call for notice, especially when recommendations affect care, access, or communication.
Be honest about limits
A tool can be useful and still limited. A transparency policy should require plain-language limits.
For example:
The tool may not work as well for patients outside the population used for testing.
The tool may be wrong if records are incomplete.
The tool should not be used as the only source for a care decision.
The tool may need extra review for rare conditions.
Honest limits do not weaken trust. They make trust possible.
Assign accountability before something goes wrong
Accountability cannot be vague. Every artificial intelligence tool should have clear owners.
A strong accountability policy defines roles such as:
A clinical owner for tools that affect care
A privacy owner for tools that use patient information
A technical owner for performance and system issues
A quality or safety owner for incident review
A senior leader or committee for final approval of high risk tools
The policy should also define decision rights. Who can approve the tool? Who can pause it? Who can change how it is used? Who signs off when monitoring shows problems?
This matters because artificial intelligence can blur responsibility. A clinician may assume the technology team approved the tool. The technology team may assume clinicians understand the output. A supplier may say the organization chose how to use it.
Patients should not fall into those gaps.
A practical example helps. Suppose a tool flags patients at risk for infection. One week, several alerts appear late. Staff report the issue. Under a clear accountability policy:
The clinical owner reviews possible patient impact.
The technical owner checks whether data feeds were delayed.
The safety team decides whether any cases need follow-up.
Leaders pause the tool if needed.
The event is documented and reviewed.
Staff receive an update on what changed.
That is accountability in action.
Require human review for care-related decisions
Artificial intelligence can assist care teams, but healthcare organizations should be careful about allowing automated decisions without human review.
A human review policy defines when a trained person must check, confirm, or override an output. For clinical care, this policy is essential.
The U.S. Food and Drug Administration reviews certain medical software when it meets the definition of a medical device. That does not mean every artificial intelligence tool is reviewed by the agency. Many tools used for administration, documentation, or support may fall outside that process. Organizations still need their own controls.
A human review policy should state:
Which outputs require review
Who is qualified to review them
How review is documented
When the tool’s suggestion may be overridden
How disagreements are handled
How patients can ask questions about decisions that affect them
For example, a system may rank patient messages by urgency. The organization might require a trained staff member to review high-risk words, symptoms, and unusual messages before routing. The tool helps sort volume, but a person remains responsible for the final action.
For higher-risk uses, the policy should be stricter. A tool may flag an imaging study for urgent review, but a qualified professional should interpret the study and make the clinical judgment.
Test for fairness and reduce bias
Bias in healthcare artificial intelligence is not a theory. It is a known risk because health data reflects real-world gaps in access, diagnosis, treatment, and documentation.
The World Health Organization has warned that artificial intelligence can improve health outcomes, but it can also worsen inequities if built or used poorly. That risk is especially serious in healthcare systems that already show differences in care by income, race, language, disability, age, or location.
A fairness and bias policy should require testing before use and monitoring after use.
What to check
Organizations should compare performance across groups when the data allows and when doing so is lawful and ethical.
Useful checks may include:
Age groups
Sex
Race and ethnicity
Preferred language
Disability status
Insurance type
Rural or urban location
Common health conditions
The goal is not to collect sensitive information without a reason. The goal is to understand whether the tool works safely and fairly for the people it affects.
What bias can look like
Bias can appear in many ways.
A tool may:
Miss symptoms more often in one group
Recommend fewer follow-up calls for patients with limited past visits
Perform poorly for people whose first language is not English
Use cost of care as a stand-in for health need
Reflect older patterns of unequal treatment
For example, if a tool predicts future health need based mostly on past healthcare spending, it may underestimate patients who needed care but could not afford or access it. That kind of design can turn past barriers into future decisions.
What to do when problems appear
A fairness policy should not stop at testing. It should require action.
Possible responses include:
Limiting how the tool is used
Adding human review for affected cases
Improving training data
Removing unfair inputs
Re-testing the tool
Pausing or retiring the tool
Fairness is not a one-time checkbox. It is part of ongoing patient safety.
Monitor tools after approval
Approval is only the start. Artificial intelligence can change in value or risk over time because patient populations change, clinical practices change, data quality changes, and staff workflows change.
A monitoring policy should define what the organization tracks and how often.
For healthcare tools, monitoring may include:
Accuracy or error patterns
False alarms
Missed cases
Staff overrides
Patient complaints
Privacy concerns
Differences across patient groups
Delays or system failures
Changes in how staff use the tool
The policy should also set trigger points. For example:
Pause the tool if serious safety concerns appear.
Review the tool if error rates rise.
Re-test the tool after major workflow changes.
Remove the tool if it no longer meets its approved purpose.
Monitoring should include people who understand care delivery. A dashboard alone is not enough. Staff feedback matters because they see how the tool behaves in real life.
Build ethics into every policy
Ethics should not sit in a separate document that no one reads. It should shape each policy.
Four ethical principles are especially useful in healthcare.
Do good
Artificial intelligence should have a clear patient, staff, or public health benefit. A tool should not be approved just because it is available.
A practical question is:
What problem does this tool solve, and how will we know it helped?
Avoid harm
The organization should identify possible harms before use. Harm may include wrong clinical suggestions, delayed care, privacy exposure, loss of trust, or unfair treatment.
Respect people
Patients should be treated as people, not just data points. Respect includes privacy, clear communication, meaningful review, and a way to ask questions or raise concerns.
Treat people fairly
Artificial intelligence should not widen gaps in care. Policies should require fairness checks, accessible communication, and special caution when tools affect access to services.
Ethical review should be practical. It should ask real questions about real use. For example:
Could this tool change who gets called first?
Could it miss patients with limited records?
Could staff trust it too much?
Could patients reasonably object to this use of their data?
Could the same goal be met with less sensitive information?
Train staff in plain language
Even the best policy fails if staff do not understand it. Training should be short, clear, and tied to everyday work.
Staff should know:
Which tools are approved
What they are allowed to enter into each tool
When human review is required
How to explain artificial intelligence use to patients
What errors or concerns look like
How to report a problem
What uses are not allowed
Training should include examples. For instance:
A staff member wants help summarizing a patient message. If the tool is not approved for patient information, they should not paste the message into it. They can use an approved tool or remove patient details only if policy allows that approach.
A clinician sees a risk score that does not match their assessment. The policy should encourage them to use clinical judgment, document the reason, and report the concern if the score seems unsafe.
Training should also reduce overreliance. People may trust computer outputs even when they are wrong, especially when those outputs look confident. Staff need permission and responsibility to question the tool.
Ask better questions of outside suppliers
Many healthcare organizations will rely on outside suppliers for artificial intelligence tools. That can be reasonable, but it does not remove responsibility from the healthcare organization.
A vendor and third-party policy should require clear answers before approval.
Useful questions include:
What is the tool intended to do?
What should it not be used for?
What data was used to build or test it?
Was it tested on patients similar to ours?
How is performance measured?
How does performance vary across patient groups?
What patient information will the supplier receive?
Will the supplier use our data to improve its tool?
Where is the data stored?
How are privacy and security protected?
How are errors reported?
What happens if we stop using the tool?
If a supplier cannot answer basic questions about purpose, data use, limits, and safety, the organization should slow down.
The National Institute of Standards and Technology’s artificial intelligence risk framework emphasizes documentation as part of trustworthy systems. In healthcare, documentation is not paperwork for its own sake. It is how organizations prove that they asked the right questions before patients were affected.
Prepare for incidents and complaints
Artificial intelligence incidents can include wrong recommendations, harmful delays, privacy problems, biased outputs, or confusing patient communication.
An incident response policy should tell staff what to report and what happens next.
Reports should include:
Unsafe or unexpected outputs
Repeated errors
Patient complaints
Privacy concerns
Biased or disrespectful language
Alerts that arrive too late
Staff workarounds that suggest the tool is not working
The response process should include review, documentation, correction, and communication. For serious issues, the organization may need to pause the tool, notify affected people, or meet legal reporting duties.
A complaint process also helps patients. If artificial intelligence affects a message, score, ranking, or recommendation, patients should have a way to ask for human review.
A simple starting checklist
Healthcare organizations can begin with a practical checklist rather than waiting for a perfect program.
Use this as a starting point:
Create an inventory of all artificial intelligence tools.
Ban patient information in unapproved tools.
Classify tools by risk.
Require privacy review for any tool using patient data.
Require clinical review for tools that affect care.
Tell staff and patients when artificial intelligence use matters.
Assign a named owner to each tool.
Test high risk tools for bias and safety.
Monitor tools after launch.
Create a clear reporting path for concerns.
Retire tools that no longer meet safety, privacy, or fairness standards.
For organizations that want structured support building policies, reviews, and training materials, review the AI governance consulting options.
FAQ
What is AI governance in healthcare?
AI governance is the set of rules, roles, and checks that guide how artificial intelligence is approved, used, monitored, and stopped in healthcare. It helps protect patients, staff, and private health information.
Does every artificial intelligence tool need the same review?
No. Review should match risk. A tool that affects diagnosis, treatment, triage, or access to care needs much stronger review than a tool used for general administrative support.
Should patients be told when artificial intelligence is used?
Patients should receive plain explanations when artificial intelligence plays a meaningful role in their care, communication, or access to services. The notice should be clear, brief, and honest about human review.
Who is responsible if an artificial intelligence tool makes a mistake?
The organization must define responsibility before use. A safe policy names the people or groups responsible for approval, clinical oversight, privacy, monitoring, and incident response.
Can artificial intelligence be used without risking privacy?
Privacy risk can be reduced, but not ignored. Organizations should limit data use, use de-identified data when possible, restrict access, review suppliers carefully, and keep patient information out of unapproved tools.
The takeaway
Artificial intelligence can support healthcare, but only when it is used with care. The safest organizations will not rely on hope, habit, or supplier promises. They will set clear policies for approval, risk, privacy, transparency, human review, fairness, monitoring, and accountability.
Good governance makes artificial intelligence easier to trust because it makes the rules visible. It tells staff what is allowed. It tells patients what to expect. It gives leaders a way to act when something goes wrong.
The goal is simple: use artificial intelligence where it helps, control it where it creates risk, and keep patient safety, privacy, and ethics at the center of every decision.
Comments